BeOne Medicines
Brent McHenry is an accomplished biostatistician with extensive experience in the pharmaceutical industry and academia. Currently serving as Director of Biostatistics at BeiGene since December 2021, Brent has previously held multiple leadership roles at Bristol Myers Squibb from June 2005, including Director, Senior Associate Director, Associate Director, Principal Statistician, Senior Biostatistician, and Research Biostatistician. Additionally, Brent was an Assistant Professor at the Medical University of South Carolina from March 2003 to May 2005. Brent holds a Doctor of Philosophy (PhD) in Biostatistics from the University of Pittsburgh, obtained in 2003.
This person is not in any teams
This person is not in any offices
BeOne Medicines
36 followers
BeOne Medicines is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of more than 11,000 colleagues spanning six continents, the Company is committed to radically improving access to medicines for far more patients who need them.